Identification of Some Chemical Constituents of the Leaves of Alstonia boonei and Bridelia ferruginea

Year 2016, Volume: 30 Issue: 1, 21 - 28, 13.12.2016

Oluwatoyin Adenike Fabiyi , Olubunmi Atolani Gabriel A Olatunji

Abstract

This study aims to investigate the phytochemical composition of the leaves of Alstonia boonei and Bridelia ferruginea. The leaves of the two plants were extracted successively with n-hexane and ethyl acetate, concentrated and fractionated over gravity silica gel column chromatography. Some fractions obtained were analyzed using gas chromatography mass spectroscopy (GC-MS).  GC-MS results indicated that the main constituents of the fractions from Alstonia boonei were fatty acid methyl esters, while the main constituents of the fractions from Bridelia ferruginea were fatty acid esters (47.46%) and triterpenoids (43.39%). Each of the fractions has at least one exclusive tetracyclic or pentacyclic triterpenoid present. Friedelan-3-one and clionasterol were present in the Alstonia boonei fractions, while beta-amyrin, lup-20(29)-en-3-one, lupeol, alpha-amyrin acetate and 4,4,6a,6b,8a,11,11,14b-octamethyl-1,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,-octadecahydro-2H-picen-3-one were present in the B. ferruginea fraction. Obviously, B. ferruginea is a reservoir to many pentacyclic triterpenoids. The pentacyclic triterpenoids may be used as a biomarker in the chemo taxonomical classification of the plants whilst acting as relevant contributors to the acclaimed biological benefits of B. ferruginea reported in traditional medical practices. The leaves of the two plants contain many bioactive compounds which may find application in pharmaceutical formulations as well as nutraceuticals and bio-pesticides preparations

Keywords

chromatography, fatty acid esters; fractions; friedelan-3-one; metabolites

References

• Addae-Mensah L, Achenbach H (1985). Terpenoids and flavonoids of Bridelia ferruginea. Phytochemistry. 24: 1817-1819.
• Asuzu IU, Ananga AO (1991). Pharmacological screening of the aqueous extract of Alstonia boonei stem bark. Fitoterapia. 63: 411-417.
• Atolani O, Olatunji GA, Fabiyi OA, Adeniji JA, Ogbole OO (2013). Phytochemicals from Kigelia pinnata Leaves shows Antioxidant and Anti-cancer potentials on Human Cancer Cell Line. Journal of Medicinal Food.16: (10) 878-885.
• Atolani O, Adeyemi OS, Akpan E, Adeosun CB, Olatunji GA (2011).Chemical Composition and Antioxidant Potentials of Kigelia pinnata Root Oil and Extracts. Excli Journal. 10: 264-273.
• Atolani O, Olatunji GA, Adeyemi OS, Fayemi O (2009). Antioxidant and Antimicrobial Activity of Cuticular Wax from Kigelia africana.–FABAD Journal of Pharmaceutical Science. 34 (4): 187-194.
• Boonyaratevej S, Bates RB, Caldera S, Suvannachut K (1990). A new triterpenoid from bridelia. Journal of Natural Product. 53: 209-211.
• Danquah CA, Koffuor GA, Annan K, Ketor EC (2012).The Anthelmintic Activity of Vernonia amygdalina (Asteraceae) and Alstonia boonei De Wild (Apocynaceae). Journal of Medical and Biomedical Sciences. 1: (1) 21-27.
• Fabiyi OA, Atolani O, Olatunji GA 2(012a) Nematicidal Activity of Alstonia boonei and Bridelia ferruginea Leaves on Meloidogyne incognita Infecting Corchorus olitorius. Albanian Journal of Agricultural Sciences. 11: 105-114.
• Fabiyi OA, Olatunji GA, Atolani O (2012b). Nematicidal Activities of Chromatographic Fractions from Alstonia boonei and Bridelia ferruginea on Meloidogyne incognita. Pakistan Journal of Nematology. 30 (2): 189-198.
• Faparusi SI, Bassir O (1982).Triterpenes from Alstonia boonei. Phytochemistry. 21: 3083-3084.
• IWU M M (1993). Handbook of Africa Medicinal Plants. Conservation International NewYork.
• Keay RWJ, Phil D, Bios FT (1989). Trees of Nigeria. Oxford University Press. New York.
• Kowalski R, (2008). Antimicrobial activity of essential oils and extracts of rosinweed (Silphium trifoliatum and Silphium integrifolium) plants used by the American Indians, Flavour Fragrance Journal. 23: 426-433.
• Kweifo-Okai G (1991). Anti-inflammatory activity of a Ghanaian antiarthritic herbal preparation. Journal of Ethnopharmacology. 33: 129-133.
• Kweifo-Okai G, Carroll AR (1992). Antiarthritic effect of lupeol. Medline. 6: 3083.
• Majekodunmi SO, Adegoke OA, Odeku OA (2008). Formulation of the extract of the stem bark of Alstonia boonei as tablet dosage form. Tropical Journal of Pharmaceutical Research.7: (2). 987-994.
• Nathaniel OO, Benjamin II, Manuele T (2010). Insecticidal properties of an alkaloid from Alstonia boonei De Wild. Journal of Biopesticides. 3: 265-270.
• Nigeria Natural Medicine Development Agency, NNMDA (2006). Medicinal Plants of Nigeria, North- central Zone. 1:79.
• Ojewole JAO (1984). Studies on the pharmacology of echitaminean alkaloid from the stem bark of Alstonia boonei (Apocynaceae). International Journal Crude Drug Research. 22:121-143.
• Olajide OA, Awe SO, Makinde JM, Ekhelar AI, Olusola A, Morebise O, Okpako DT (2000). Studies on the anti-inflammatory, antipyretic analgesic properties of Alstonia boonei stem bark. Journal of Ethnopharmacology. 71: (1-2), 179-186.
• Oliver-Bever B (1986). Medicinal plants in tropical West Africa. Cambridge. 258-260.
• Raymond-Hamet R. (1999). Comp. Rend. Sc. Soc, Biol. Paris 116:1022.
• Salina D (2001). Identification and cytotoxic activity of some alkaloids. Planta Medica 67:443.
• Simon G (2006). An Introduction to Planar Chromatography. In Natural Products Isolation 2nd Ed. Human Press, New Jersey.